Anal cancer: current and future methodology (Q36581056)

15 August 2017

1 reference

title

Anal cancer: current and future methodology (English)

1 reference

15 August 2017

Cathy Eng

1

1 reference

15 August 2017

publication date

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

24

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

535-544

1 reference

15 August 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Cancer of the anal canal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal: potential implications of a new ultrasound staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Assessment of the accuracy of transrectal ultrasonography in anorectal neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

The impact of treatment factors on local control in T2-T3 anal carcinomas treated by radiotherapy with or without chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

The National Cancer Data Base report on carcinoma of the anus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Chemotherapy and radiation of anal canal cancer: the first approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Molecular biology of squamous cell carcinoma of the anus: a comparison of HIV-positive and HIV-negative patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Squamous cell carcinoma of the anal margin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Chemoradiation for adenocarcinoma of the anus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Management of primary anal canal adenocarcinoma: a large retrospective study from the Rare Cancer Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Anal cytology as a screening tool for anal squamous intraepithelial lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07357900600815208

10.1080/07357900600815208

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference